Your browser doesn't support javascript.
The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial.
Doaei, Saeid; Gholami, Somayeh; Rastgoo, Samira; Gholamalizadeh, Maryam; Bourbour, Fatemeh; Bagheri, Seyedeh Elaheh; Samipoor, Forough; Akbari, Mohammad Esmail; Shadnoush, Mahdi; Ghorat, Fereshteh; Mosavi Jarrahi, Seyed Alireza; Ashouri Mirsadeghi, Narjes; Hajipour, Azadeh; Joola, Parvin; Moslem, Alireza; Goodarzi, Mark O.
  • Doaei S; Research Center of Health and Environment, School of Health, Guilan University of Medical Sciences, Rasht, Iran.
  • Gholami S; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Rastgoo S; Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran.
  • Gholamalizadeh M; National Nutrition and Food Technology Research Institute, Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Bourbour F; Student Research Committee, Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Bagheri SE; National Nutrition and Food Technology Research Institute, Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Samipoor F; School of Paramedicine, Guilan University of Medical Sciences, Langroud, Iran.
  • Akbari ME; Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran.
  • Shadnoush M; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Ghorat F; Department of Clinical Nutrition, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Mosavi Jarrahi SA; Traditional and Complementary Medicine Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran.
  • Ashouri Mirsadeghi N; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Hajipour A; National Nutrition and Food Technology Research Institute, Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Joola P; School of Health, Qazvin University of Medical Sciences, Qazvin, Iran.
  • Moslem A; Department of Non-Communicable Disease, Deputy of Health Services, Dezful University of Medical Sciences, Dezful, Iran.
  • Goodarzi MO; Iranian Research Center on Healthy Aging, Sabzevar University of Medical Sciences, Sabzevar, Iran. Crc.sbmu2018@gmail.com.
J Transl Med ; 19(1): 128, 2021 03 29.
Article in English | MEDLINE | ID: covidwho-1158209
ABSTRACT

BACKGROUND:

Omega-3 polyunsaturated fatty acids (n3-PUFAs) may exert beneficial effects on the immune system of patients with viral infections. This paper aimed to examine the effect of n3-PUFA supplementation on inflammatory and biochemical markers in critically ill patients with COVID-19.

METHODS:

A double-blind, randomized clinical trial study was conducted on 128 critically ill patients infected with COVID-19 who were randomly assigned to the intervention (fortified formula with n3-PUFA) (n = 42) and control (n = 86) groups. Data on 1 month survival rate, blood glucose, sodium (Na), potassium (K), blood urea nitrogen (BUN), creatinine (Cr), albumin, hematocrit (HCT), calcium (Ca), phosphorus (P), mean arterial pressure (MAP), O2 saturation (O2sat), arterial pH, partial pressure of oxygen (PO2), partial pressure of carbon dioxide (PCO2), bicarbonate (HCO3), base excess (Be), white blood cells (WBCs), Glasgow Coma Scale (GCS), hemoglobin (Hb), platelet (Plt), and the partial thromboplastin time (PTT) were collected at baseline and after 14 days of the intervention.

RESULTS:

The intervention group had significantly higher 1-month survival rate and higher levels of arterial pH, HCO3, and Be and lower levels of BUN, Cr, and K compared with the control group after intervention (all P < 0.05). There were no significant differences between blood glucose, Na, HCT, Ca, P, MAP, O2sat, PO2, PCO2, WBCs, GCS, Hb, Plt, PTT, and albumin between two groups.

CONCLUSION:

Omega-3 supplementation improved the levels of several parameters of respiratory and renal function in critically ill patients with COVID-19. Further clinical studies are warranted. Trial registry Name of the registry This study was registered in the Iranian Registry of Clinical Trials (IRCT); Trial registration number IRCT20151226025699N3; Date of registration 2020.5.20; URL of trial registry record https//en.irct.ir/trial/48213.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Fatty Acids, Omega-3 / Critical Illness / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Traditional medicine Country/Region as subject: Asia Language: English Journal: J Transl Med Year: 2021 Document Type: Article Affiliation country: S12967-021-02795-5

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Fatty Acids, Omega-3 / Critical Illness / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Traditional medicine Country/Region as subject: Asia Language: English Journal: J Transl Med Year: 2021 Document Type: Article Affiliation country: S12967-021-02795-5